Abstract:Doxorubicin-loaded PLGA nanoparticles (DOX-PLGA NPs) was prepared by double emulsion (W/O/W) solvent evaporation method with the biodegradable materials-poly (lactic-co-glycolic acid) (PLGA) used as carrier materials. Single-factor test was used to investigate the influence of the type and ratio of the organic phase, the amount of surfactant, PLGA concentration, the ratio of external water phase and oil phase (W/O), the ratio of doxorubicin and PLGA, ultrasonic time and stirring time on the preparation of nanoparticles. The best formulation and preparation conditions were optimized by orthogonal test based on single-factor test, evaluation indicator as particle size and entrapment efficiency, and the results were analyzed by overall desirability. And the in vitro release behaviors of the nanoparticles were studied as well. The size distribution, zeta potential, morphology of DOX-PLGA NPs were characterized by laser light scattering and transmission electron microscopy; encapsulation efficiency and releasing behavior of DOX-PLGA NPs in vitro were investigated by ultraviolet spectrophotometry. The results show that the DOX-PLGA NPs are regularly spherical in shape with the mean size of (189.2 +/- 5.3) nm, and the zeta-potential of the NPs is about (-28.32 +/- 0.52) mV. Drug loading and encapsulation efficiency are estimated to be (73.16 +/- 0.43) % and (1.51 +/- 0.07) %, respectively. The cumulative percentage of the drug released is 90.34%, and the in vitro release behavior made up of initial burst release and sustained-release could be described by the bidirectional kinetic equation. The results indicate that hydrophilic small-molecule drugs could be successfully entrapped into PLGA-NPs. With optimization of the formulation and preparation conditions, we obtained uniform and stable DOX-PLGA NPs with sustained release character in vitro and pH-sensitive property, which could provide the experimental basis for the development of a new anti-tumor sustained-release formulation.

Preparation and in Vitro Properties of Oridonin-Loaded Polylactic-acid Nanoparticles

Preparation and Characterization of Oridonin-loaded Poly (caprolactone)-Poly (ethylene oxide)-Poly (caprolactone) Copolymer Nanoparticles

Preparation And Characteristics Of Oridonin-Loaded Nanostructured Lipid Carriers As A Controlled-Release Delivery System

Studies on the Oridonin-Loaded Poly(d,l-Lactic Acid) Nanoparticles in Vitro and in Vivo

Preparation of oridonin-loaded solid lipid nanoparticles and studies on them in vitro and in vivo

Studies on preparation and property of oridonin solid lipid nanoparticles

Formulation and Process Optimization of Doxorubicin-Loaded PLGA Nanoparticles and Its in Vitro Release

Preparation,characterization and drug release properties of naringenin polylactic acid nanoparticles

Preparation and in vitro release of polylactic acid nanoparticles loaded with isoniazid and rifampicin

In vitro and in vivo evaluation of oridonin-loaded long circulating nanostructured lipid carriers

Preparation and in Vitro Controlled Release of Drug-Loaded Agarose Acetate Nanoparticles

Preparation of VEGF Antisense Oligodeoxynucleotide Loaded Polyactic-Co-glycolic Acid Nanoparticles and Their Physicochemical Properties

In Vivo Studies On The Oridonin-Loaded Nanostructured Lipid Carriers

Crystalline Drug Aconitine-Loaded Poly(d,l-Lactide-coglycolide) Nanoparticles: Preparation and in Vitro Release.

Optimizing Preparation of Arsenic Trioxide-Loaded Polylacticco-Glycolic Nanoparticles

[Study on Preparation and Oral Efficacy of Insulin-Loaded Poly(lactic-Co-glycolic Acid) Nanoparticles].

Preparation and in Vitro Evaluation of Saponins PD-loaded Eudragit L100 Nanoparticles

Study on Preparation of Adriamycin-loaded PLGA Nanoparticles in Vitro

Preparation of drug-loaded poly (D, L-lactide-co-glycolide) nanoparticles and characterization of release behavior in vitro

Preparation and Physical Characterization of Poly-Lactic-co-glycolic Acid Nanoparticles Loaded with Thymopentin for Oral Administration

Preparation and in Vitro Release of Vinblastin-loaded Poly(lacticacid) Nanoparticle